Denali Therapeutics (DNLI) Earnings Date & Reports

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DNLI is expected to report earnings to fall 15.77% to -58 cents per share on July 30

Denali Therapeutics DNLI Stock Earnings Reports

Q2'26

Est.

$-0.58

Q1'26

Missed

by $0.03

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.01

Q2'25

Missed

by $0.01

The last earnings report on May 07 showed earnings per share of -68 cents, missing the estimate of -66 cents. With 646.03K shares outstanding, the current market capitalization sits at 3.82B.

View a ticker or compare two or three

Compare

DNLI

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for DNLI